MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-06-2026
Repligen Corporation Operating Expenses 2011-2026 | RGEN
Annual Operating Expenses Repligen Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 115 M | 81.5 M | 60.2 M | 38.2 M | 30.4 M | 22.8 M | 20 M | 23.7 M | 20.5 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 115 M | 20 M | 45.8 M |
Quarterly Operating Expenses Repligen Corporation
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 91.2 M | 73.1 M | 67.9 M | 64.2 M | 63.6 M | 61.5 M | 59.6 M | 49.5 M | 44.1 M | 41.6 M | 43.5 M | 38.9 M | 38.3 M | 37 M | 27 M | 24.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 91.2 M | 24.9 M | 51.6 M |
Operating Expenses of other stocks in the Medical instruments industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
The Cooper Companies
COO
|
1.23 B | $ 60.38 | - | $ 12 B |  USA |
 |
Atrion Corporation
ATRI
|
39.8 K | - | - | $ 810 M | USA |
 |
Luminex Corporation
LMNX
|
205 M | - | - | $ 1.75 B | USA |
 |
Repro Med Systems
KRMD
|
28.6 M | $ 3.98 | - | $ 184 M | USA |
 |
ICU Medical
ICUI
|
779 M | $ 122.99 | 0.78 % | $ 3.03 B | USA |
 |
iRhythm Technologies
IRTC
|
585 M | $ 114.16 | - | $ 3.65 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
7.99 M | - | -9.52 % | $ 20.6 M | USA |
 |
Intuitive Surgical
ISRG
|
3.7 B | $ 428.06 | - | $ 153 B | USA |
 |
Alcon
ALC
|
3.37 B | $ 64.0 | -0.03 % | $ 40.4 B |  Schweiz |
 |
LeMaitre Vascular
LMAT
|
111 M | $ 99.5 | - | $ 2.25 B | USA |
 |
Masimo Corporation
MASI
|
1.27 B | $ 178.35 | - | $ 9.51 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
72.9 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
388 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
8.44 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
1.07 B | - | -0.05 % | $ 10.3 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
20.2 M | - | - | $ 28.6 M | USA |
 |
Envista Holdings Corporation
NVST
|
2.27 B | $ 23.86 | - | $ 4.01 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
1.05 B | - | -0.02 % | $ 16.3 B | USA |
 |
electroCore
ECOR
|
40.9 M | $ 6.43 | - | $ 54.5 K | USA |
 |
Haemonetics Corporation
HAE
|
527 M | $ 57.12 | - | $ 2.87 B | USA |
 |
Isoray
ISR
|
114 M | - | 0.03 % | $ 108 M | USA |
 |
STAAR Surgical Company
STAA
|
100 M | $ 32.01 | - | $ 1.59 B | USA |
 |
Glaukos Corporation
GKOS
|
368 M | $ 142.15 | - | $ 6.88 B | USA |
 |
STERIS plc
STE
|
1.54 B | $ 215.98 | - | $ 21.3 B | USA |
 |
Teleflex Incorporated
TFX
|
1.05 B | $ 130.28 | - | $ 5.81 B | USA |
 |
InfuSystem Holdings
INFU
|
68.4 M | $ 8.61 | - | $ 178 M | USA |
 |
Microbot Medical
MBOT
|
9.09 K | $ 1.85 | - | $ 84.7 M |  Israel |
 |
Milestone Scientific
MLSS
|
12.1 M | $ 0.34 | -0.87 % | $ 27.9 M | USA |
 |
Merit Medical Systems
MMSI
|
554 M | $ 62.56 | - | $ 3.7 B | USA |
 |
Utah Medical Products
UTMD
|
11.8 M | $ 63.7 | - | $ 206 M | USA |
 |
West Pharmaceutical Services
WST
|
301 M | $ 300.19 | - | $ 21.7 B | USA |
 |
Pulse Biosciences
PLSE
|
48 M | $ 27.1 | - | $ 1.83 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.72 B | $ 10.41 | - | $ 2.08 B | USA |
 |
Retractable Technologies
RVP
|
21.2 M | $ 0.69 | 0.01 % | $ 20.7 M | USA |
 |
Pro-Dex
PDEX
|
8.82 M | $ 58.65 | - | $ 193 M | USA |
 |
Predictive Oncology
POAI
|
13.1 M | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
17.8 M | $ 21.06 | - | $ 1.01 B | USA |
 |
Stereotaxis
STXS
|
39.2 M | $ 1.94 | - | $ 176 M | USA |
 |
Baxter International
BAX
|
3.88 B | $ 17.78 | - | $ 9.12 B | USA |
 |
ResMed
RMD
|
1.02 B | $ 202.46 | - | $ 29.6 B | USA |
 |
AtriCure
ATRC
|
410 M | $ 28.15 | - | $ 1.34 B | USA |
 |
Harvard Bioscience
HBIO
|
98.5 M | $ 5.52 | - | $ 245 M | USA |
 |
NeuroMetrix
NURO
|
10.5 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
198 M | $ 11.03 | - | $ 451 M | USA |
 |
Becton, Dickinson and Company
BDX
|
6.05 B | $ 144.47 | - | $ 41.6 B | USA |
 |
Nephros
NEPH
|
10.5 M | $ 3.34 | - | $ 35.4 M | USA |
 |
OraSure Technologies
OSUR
|
120 M | $ 2.95 | - | $ 217 M | USA |